Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_assertion type Assertion NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_head.
- NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_assertion description "[However, mutations inATP13A2, PLA2G6 and FBX07 are often associated with rapidly progressive parkinsonism and with additional features including pyramidal signs, cognitive decline and loss of sustained Levodopa responsiveness.Clarifying the phenotypes of each of these autosomal-recessive parkinsonian-pyramidal syndromes and understanding the mechanism ot these causative gene products might illuminate the pathogenesis of dopaminergic neuronal degeneration also in the common forms of PD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_provenance.
- NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_assertion evidence source_evidence_literature NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_provenance.
- NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_assertion SIO_000772 23196729 NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_provenance.
- NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_assertion wasDerivedFrom befree-2016 NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_provenance.
- NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_assertion wasGeneratedBy ECO_0000203 NP1032296.RA_yoj-S7YuxZN-gdowD3tckJci_175RNgFBx3LNacBAw130_provenance.